UniProt ID | MK67I_HUMAN | |
---|---|---|
UniProt AC | Q9BYG3 | |
Protein Name | MKI67 FHA domain-interacting nucleolar phosphoprotein | |
Gene Name | NIFK | |
Organism | Homo sapiens (Human). | |
Sequence Length | 293 | |
Subcellular Localization | Nucleus, nucleolus. Chromosome. Localizes to mitotic chromosomes in conjunction with MKI67. | |
Protein Description | ||
Protein Sequence | MATFSGPAGPILSLNPQEDVEFQKEVAQVRKRITQRKKQEQLTPGVVYVRHLPNLLDETQIFSYFSQFGTVTRFRLSRSKRTGNSKGYAFVEFESEDVAKIVAETMNNYLFGERLLECHFMPPEKVHKELFKDWNIPFKQPSYPSVKRYNRNRTLTQKLRMEERFKKKERLLRKKLAKKGIDYDFPSLILQKTESISKTNRQTSTKGQVLRKKKKKVSGTLDTPEKTVDSQGPTPVCTPTFLERRKSQVAELNDDDKDDEIVFKQPISCVKEEIQETQTPTHSRKKRRRSSNQ | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 | Acetylation | ------MATFSGPAG ------CCCCCCCCC | 19.83 | 22223895 | |
38 | Ubiquitination | KRITQRKKQEQLTPG HHHHHHHHHHHCCCC | 62.35 | 24816145 | |
38 | Sumoylation | KRITQRKKQEQLTPG HHHHHHHHHHHCCCC | 62.35 | 28112733 | |
38 | Sumoylation | KRITQRKKQEQLTPG HHHHHHHHHHHCCCC | 62.35 | - | |
82 | Phosphorylation | RLSRSKRTGNSKGYA EEECCCCCCCCCCEE | 44.44 | - | |
88 | Phosphorylation | RTGNSKGYAFVEFES CCCCCCCEEEEEECC | 10.70 | - | |
109 | Phosphorylation | VAETMNNYLFGERLL HHHHHHHHHHCCHHH | 9.82 | 23663014 | |
114 | Methylation | NNYLFGERLLECHFM HHHHHCCHHHCCCCC | 44.97 | 26529540 | |
128 | Ubiquitination | MPPEKVHKELFKDWN CCHHHHHHHHHHCCC | 60.13 | 29967540 | |
139 | Sumoylation | KDWNIPFKQPSYPSV HCCCCCCCCCCCHHH | 56.81 | - | |
139 | Ubiquitination | KDWNIPFKQPSYPSV HCCCCCCCCCCCHHH | 56.81 | 23000965 | |
139 | Sumoylation | KDWNIPFKQPSYPSV HCCCCCCCCCCCHHH | 56.81 | 28112733 | |
139 | Methylation | KDWNIPFKQPSYPSV HCCCCCCCCCCCHHH | 56.81 | 44496799 | |
142 | Phosphorylation | NIPFKQPSYPSVKRY CCCCCCCCCHHHHHH | 47.37 | 28152594 | |
143 | Phosphorylation | IPFKQPSYPSVKRYN CCCCCCCCHHHHHHC | 13.25 | 28152594 | |
145 | Phosphorylation | FKQPSYPSVKRYNRN CCCCCCHHHHHHCCC | 31.85 | 28152594 | |
154 | Phosphorylation | KRYNRNRTLTQKLRM HHHCCCCCHHHHHHH | 37.39 | - | |
156 | Phosphorylation | YNRNRTLTQKLRMEE HCCCCCHHHHHHHHH | 24.05 | - | |
158 | Ubiquitination | RNRTLTQKLRMEERF CCCCHHHHHHHHHHH | 32.59 | 27667366 | |
179 | Ubiquitination | LRKKLAKKGIDYDFP HHHHHHHCCCCCCCH | 56.33 | 33845483 | |
179 | Sumoylation | LRKKLAKKGIDYDFP HHHHHHHCCCCCCCH | 56.33 | 28112733 | |
179 | Methylation | LRKKLAKKGIDYDFP HHHHHHHCCCCCCCH | 56.33 | 23748837 | |
179 | Acetylation | LRKKLAKKGIDYDFP HHHHHHHCCCCCCCH | 56.33 | 27452117 | |
183 | Phosphorylation | LAKKGIDYDFPSLIL HHHCCCCCCCHHHHH | 19.98 | 28796482 | |
187 | Phosphorylation | GIDYDFPSLILQKTE CCCCCCHHHHHHHHH | 28.21 | 27642862 | |
192 | Acetylation | FPSLILQKTESISKT CHHHHHHHHHCCCCC | 51.30 | 26051181 | |
192 | Ubiquitination | FPSLILQKTESISKT CHHHHHHHHHCCCCC | 51.30 | 29967540 | |
192 | Sumoylation | FPSLILQKTESISKT CHHHHHHHHHCCCCC | 51.30 | 28112733 | |
198 | 2-Hydroxyisobutyrylation | QKTESISKTNRQTST HHHHCCCCCCCCCCC | 48.42 | - | |
199 | Phosphorylation | KTESISKTNRQTSTK HHHCCCCCCCCCCCH | 28.92 | - | |
204 | Phosphorylation | SKTNRQTSTKGQVLR CCCCCCCCCHHHHHH | 21.56 | 28857561 | |
206 | Ubiquitination | TNRQTSTKGQVLRKK CCCCCCCHHHHHHHH | 47.30 | 29967540 | |
218 | Phosphorylation | RKKKKKVSGTLDTPE HHHHCCCCCCCCCCC | 34.63 | 29255136 | |
220 | Phosphorylation | KKKKVSGTLDTPEKT HHCCCCCCCCCCCCC | 17.60 | 29255136 | |
223 | Phosphorylation | KVSGTLDTPEKTVDS CCCCCCCCCCCCCCC | 36.14 | 19664994 | |
226 | Acetylation | GTLDTPEKTVDSQGP CCCCCCCCCCCCCCC | 55.86 | 26051181 | |
227 | Phosphorylation | TLDTPEKTVDSQGPT CCCCCCCCCCCCCCC | 28.08 | 29255136 | |
230 | Phosphorylation | TPEKTVDSQGPTPVC CCCCCCCCCCCCCCC | 32.47 | 29255136 | |
234 | Phosphorylation | TVDSQGPTPVCTPTF CCCCCCCCCCCCHHH | 34.87 | 29255136 | |
237 | Glutathionylation | SQGPTPVCTPTFLER CCCCCCCCCHHHHHH | 3.87 | 22555962 | |
238 | Phosphorylation | QGPTPVCTPTFLERR CCCCCCCCHHHHHHH | 26.12 | 29255136 | |
240 | Phosphorylation | PTPVCTPTFLERRKS CCCCCCHHHHHHHHH | 23.77 | 29255136 | |
244 | Methylation | CTPTFLERRKSQVAE CCHHHHHHHHHHHHC | 54.17 | 26529540 | |
245 | Methylation | TPTFLERRKSQVAEL CHHHHHHHHHHHHCC | 33.33 | 26529540 | |
247 | Phosphorylation | TFLERRKSQVAELND HHHHHHHHHHHCCCC | 28.24 | 29255136 | |
257 | Acetylation | AELNDDDKDDEIVFK HCCCCCCCCCCEEEC | 74.25 | 26051181 | |
264 | Acetylation | KDDEIVFKQPISCVK CCCCEEECCCCHHHH | 44.25 | 26051181 | |
268 | Phosphorylation | IVFKQPISCVKEEIQ EEECCCCHHHHHHHH | 21.38 | 28102081 | |
271 | Acetylation | KQPISCVKEEIQETQ CCCCHHHHHHHHHCC | 54.69 | 26051181 | |
271 | Sumoylation | KQPISCVKEEIQETQ CCCCHHHHHHHHHCC | 54.69 | - | |
271 | Sumoylation | KQPISCVKEEIQETQ CCCCHHHHHHHHHCC | 54.69 | 25114211 | |
277 | Phosphorylation | VKEEIQETQTPTHSR HHHHHHHCCCCCCHH | 22.74 | 29255136 | |
279 | Phosphorylation | EEIQETQTPTHSRKK HHHHHCCCCCCHHHH | 37.26 | 29255136 | |
281 | Phosphorylation | IQETQTPTHSRKKRR HHHCCCCCCHHHHHH | 35.55 | 29255136 | |
283 | Phosphorylation | ETQTPTHSRKKRRRS HCCCCCCHHHHHHHC | 48.55 | 29255136 | |
284 | Methylation | TQTPTHSRKKRRRSS CCCCCCHHHHHHHCC | 40.69 | 26529540 | |
290 | Phosphorylation | SRKKRRRSSNQ---- HHHHHHHCCCC---- | 31.65 | - | |
291 | Phosphorylation | RKKRRRSSNQ----- HHHHHHCCCC----- | 37.12 | - |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
230 | S | Phosphorylation | Kinase | GSK3A | P49840 | PSP |
230 | S | Phosphorylation | Kinase | GSK3B | P49841 | PSP |
234 | T | Phosphorylation | Kinase | GSK3A | P49840 | PSP |
234 | T | Phosphorylation | Kinase | GSK3B | P49841 | PSP |
238 | T | Phosphorylation | Kinase | CDK1 | P06493 | PSP |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of MK67I_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, PHOSPHORYLATION [LARGESCALE ANALYSIS] AT THR-223; THR-234 AND THR-238, AND MASSSPECTROMETRY. | |
Phosphorylation | |
Reference | PubMed |
"Sequential phosphorylation and multisite interactions characterizespecific target recognition by the FHA domain of Ki67."; Byeon I.-J., Li H., Song H., Gronenborn A.M., Tsai M.-D.; Nat. Struct. Mol. Biol. 12:987-993(2005). Cited for: STRUCTURE BY NMR OF 226-269 IN COMPLEX WITH MKI67, MASS SPECTROMETRY,MUTAGENESIS OF SER-230; THR-234; PRO-235; THR-238 AND PRO-239, ANDPHOSPHORYLATION AT SER-230; THR-234 AND THR-238. | |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-234; THR-238; SER-247AND THR-279, AND MASS SPECTROMETRY. | |
"Evaluation of the low-specificity protease elastase for large-scalephosphoproteome analysis."; Wang B., Malik R., Nigg E.A., Korner R.; Anal. Chem. 80:9526-9533(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-218; THR-220; THR-223;SER-230; THR-234; SER-247 AND THR-279, AND MASS SPECTROMETRY. | |
"Global proteomic profiling of phosphopeptides using electron transferdissociation tandem mass spectrometry."; Molina H., Horn D.M., Tang N., Mathivanan S., Pandey A.; Proc. Natl. Acad. Sci. U.S.A. 104:2199-2204(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-234; THR-240 ANDSER-247, AND MASS SPECTROMETRY. | |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, PHOSPHORYLATION [LARGESCALE ANALYSIS] AT THR-223; THR-234 AND THR-238, AND MASSSPECTROMETRY. | |
"Combining protein-based IMAC, peptide-based IMAC, and MudPIT forefficient phosphoproteomic analysis."; Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D.,Yates J.R. III; J. Proteome Res. 7:1346-1351(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-238, AND MASSSPECTROMETRY. | |
"Phosphoproteome analysis of the human mitotic spindle."; Nousiainen M., Sillje H.H.W., Sauer G., Nigg E.A., Koerner R.; Proc. Natl. Acad. Sci. U.S.A. 103:5391-5396(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-234, AND MASSSPECTROMETRY. | |
"Structure of human Ki67 FHA domain and its binding to aphosphoprotein fragment from hNIFK reveal unique recognition sites andnew views to the structural basis of FHA domain functions."; Li H., Byeon I.-J., Ju Y., Tsai M.-D.; J. Mol. Biol. 335:371-381(2004). Cited for: PHOSPHORYLATION AT THR-234, AND INTERACTION WITH MKI67. |